AvatarAdan salinasCell Biology Melanoma Resistance to Checkpoint Therapy Scrutinized with Perturb-CITE-Seq Genetic Engineering & Biotechnology News - Kevin Mayer Immune checkpoint inhibitors (ICIs), drugs that release the immune system’s “brakes,” are meant to expose cancer to the full force of the immune …
AvatarAdan salinasCell Biology Nanodevices for cancer vaccination nature.com - Hongjun Li, Zhen Gu An elaborate DNA origami tubular nanodevice encapsulating antigens and adjuvants protects mice from cancer through tumour-specific …
AvatarAdan salinasTumors Blocking a Treg Mechanism Can Scorch Tumors without Stoking Autoimmunity Genetic Engineering & Biotechnology News - Kevin Mayer Regulatory T cells (Tregs) may restrain the immune system everywhere—not just in healthy tissue, but also in tumors, where the immune system ought to …
AvatarAdan salinasPlacebos Sipuleucel-T (Provenge) Injection: The First Immunotherapy Agent (Vaccine) For Hormone-Refractory Prostate Cancer nih.gov - Enock Anassi, MD, PharmD and Uche Anadu Ndefo, PharmD, BCPS Sipuleucel-T (Provenge) Injection The First Immunotherapy Agent (Vaccine) For Hormone-Refractory Prostate Cancer Among the leading causes of …
AvatarAdan salinasCapital Raising Cyteir adds $80M to steer to Phase 2 with lead cancer drug, then maybe an IPO - MedCity News medcitynews.com - By Frank Vinluan Cyteir Therapeutics’ lead program in cancer is on track to start mid-stage testing later this year and the company plans to support that study with a …
